FDA Inspection 1217958 — University of Pittsburg Medical Center, Hillman Cancer Center

University of Pittsburg Medical Center, Hillman Cancer Center — FEI 3002965668

The FDA completed an inspection of University of Pittsburg Medical Center, Hillman Cancer Center on July 21, 2023 in Carlisle, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 21, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Carlisle, PA (United States)